1. STAT3 governs the HIF-1α response in IL-15 primed human NK cells.
- Author
-
Coulibaly A, Velásquez SY, Kassner N, Schulte J, Barbarossa MV, and Lindner HA
- Subjects
- Cell Degranulation, Cell Hypoxia, Flow Cytometry, Glycolysis, Humans, Immunophenotyping, K562 Cells, Killer Cells, Natural immunology, Killer Cells, Natural metabolism, Mechanistic Target of Rapamycin Complex 1 metabolism, Phosphorylation, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Interleukin-15 pharmacology, Killer Cells, Natural drug effects, STAT3 Transcription Factor physiology
- Abstract
Natural killer (NK) cells mediate innate host defense against microbial infection and cancer. Hypoxia and low glucose are characteristic for these tissue lesions but do not affect early interferon (IFN) γ and CC chemokine release by interleukin 15 (IL-15) primed human NK cells in vitro. Hypoxia inducible factor 1α (HIF-1α) mediates cellular adaption to hypoxia. Its production is supported by mechanistic target of rapamycin complex 1 (mTORC1) and signal transducer and activator of transcription 3 (STAT3). We used chemical inhibition to probe the importance of mTORC1 and STAT3 for the hypoxia response and of STAT3 for the cytokine response in isolated and IL-15 primed human NK cells. Cellular responses were assayed by magnetic bead array, RT-PCR, western blotting, flow cytometry, and metabolic flux analysis. STAT3 but not mTORC1 activation was essential for HIF-1α accumulation, glycolysis, and oxygen consumption. In both primed normoxic and hypoxic NK cells, STAT3 inhibition reduced the secretion of CCL3, CCL4 and CCL5, and it interfered with IL-12/IL-18 stimulated IFNγ production, but it did not affect cytotoxic granule degranulation up on target cell contact. We conclude that IL-15 priming promotes the HIF-1α dependent hypoxia response and the early cytokine response in NK cells predominantly through STAT3 signaling.
- Published
- 2021
- Full Text
- View/download PDF